Poland· PL-100489778
Omjjara
A medicinal product containing momelotinibum, registered in Poland by GlaxoSmithKline Trading Services Limited.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Momelotinibum
- Manufacturer
- GlaxoSmithKline Trading Services Limited
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991526191
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Momelotinibum in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOmjjara 200 mgGlaxoSmithKline Trading Services
- SwitzerlandOmjjara 200 mg, FilmtablettenGlaxoSmithKline AG
- CzechiaOMJJARAGlaxoSmithKline Trading Services Limited, Dublin
- SpainOMJJARA 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGlaxosmithkline Trading Services Limited
- FinlandOmjjaraGlaxosmithkline Trading Services Limited
- FranceOMJJARA 200 mg, comprimé pelliculéGLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- IrelandOmjjara 200 mg film-coated tabletsGlaxoSmithKline Trading Services Limited
- IcelandOmjjaraGlaxoSmithKline Trading Services Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Omjjara
- Liechtenstein · Omjjara
- Norway · Omjjara
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f244c643-b78b-4a3b-a4fa-3a10e3129912 GET /v1/drugs/f244c643-b78b-4a3b-a4fa-3a10e3129912?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "200 mg",
"packaging": "05909991526191 ¦ Rpz ¦ EU/1/23/1782/003 ¦ 152060\n1 butelka 30 tabl.\n¦ UR/Z/4c/129/26 - 05909991526191",
"substance": "Momelotinibum 200 mg",
"common_name": "Momelotinibum",
"pl_product_id": "100489778",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about momelotinibum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.